MGMT promoter methylation in Peruvian patients with glioblastoma

PURPOSE: O(6)-methylguanine–DNA methyltransferase (MGMT) promoter methylation predicts the outcome and response to alkylating chemotherapy in glioblastoma. The aim of this study is to evaluate the prevalence of MGMT methylation in Peruvian glioblastoma cases. PATIENTS AND METHODS: We evaluated retro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ecancermedicalscience
Main Authors: Belmar-Lopez, Carolina, Castaneda, Carlos A, Castillo, Miluska, García-Corrochano, Pamela, Orrego, Enrique, Meléndez, Barbara, Casavilca, Sandro, Flores, Claudio
Formato: Artigo
Idioma:Inglês
Publicado em: Cancer Intelligence 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834313/
https://ncbi.nlm.nih.gov/pubmed/29515653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2018.812
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados